Andrew Mok
Stock Analyst at Barclays
(2.35)
# 2,533
Out of 4,944 analysts
207
Total ratings
47.14%
Success rate
-4.24%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $45 → $31 | $20.33 | +52.48% | 15 | Aug 7, 2025 | |
| DVA DaVita | Maintains: Equal-Weight | $169 → $160 | $132.08 | +21.14% | 11 | Aug 7, 2025 | |
| EHC Encompass Health | Maintains: Buy | $130 → $140 | $118.63 | +18.01% | 17 | Aug 6, 2025 | |
| AGL agilon health | Maintains: Underweight | $3 → $1.5 | $0.89 | +68.26% | 4 | Aug 6, 2025 | |
| CVS CVS Health | Maintains: Overweight | $79 → $80 | $65.51 | +22.12% | 10 | Aug 1, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $385 → $354 | $280.47 | +26.22% | 7 | Aug 1, 2025 | |
| ALHC Alignment Healthcare | Upgrades: Equal-Weight | $9 → $13 | $14.64 | -11.20% | 5 | Jul 31, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $268 → $275 | $274.94 | +0.02% | 11 | Jul 31, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $257 → $259 | $175.21 | +47.82% | 23 | Jul 30, 2025 | |
| HCA HCA Healthcare | Maintains: Overweight | $416 → $390 | $390.31 | -0.08% | 11 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $186 | $157.31 | +18.24% | 8 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $208 | $170.48 | +22.01% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $2.56 | +36.72% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $17 → $11 | $14.98 | -26.57% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $358 → $327 | $292.48 | +11.80% | 11 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $350 → $337 | $261.57 | +28.84% | 11 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $65 → $45 | $26.17 | +71.95% | 9 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $5.5 | $7.24 | -24.03% | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $25 → $24 | $22.98 | +4.44% | 4 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $23 → $24 | $20.71 | +15.89% | 8 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $36 | $29.10 | +23.71% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $60 | $63.60 | -5.66% | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $113.06 | -26.59% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.54 | +59.15% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $100.95 | -5.89% | 7 | Aug 2, 2022 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $45 → $31
Current: $20.33
Upside: +52.48%
DaVita
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $169 → $160
Current: $132.08
Upside: +21.14%
Encompass Health
Aug 6, 2025
Maintains: Buy
Price Target: $130 → $140
Current: $118.63
Upside: +18.01%
agilon health
Aug 6, 2025
Maintains: Underweight
Price Target: $3 → $1.5
Current: $0.89
Upside: +68.26%
CVS Health
Aug 1, 2025
Maintains: Overweight
Price Target: $79 → $80
Current: $65.51
Upside: +22.12%
The Cigna Group
Aug 1, 2025
Maintains: Overweight
Price Target: $385 → $354
Current: $280.47
Upside: +26.22%
Alignment Healthcare
Jul 31, 2025
Upgrades: Equal-Weight
Price Target: $9 → $13
Current: $14.64
Upside: -11.20%
Humana
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $268 → $275
Current: $274.94
Upside: +0.02%
Universal Health Services
Jul 30, 2025
Maintains: Overweight
Price Target: $257 → $259
Current: $175.21
Upside: +47.82%
HCA Healthcare
Jul 28, 2025
Maintains: Overweight
Price Target: $416 → $390
Current: $390.31
Upside: -0.08%
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $270 → $186
Current: $157.31
Upside: +18.24%
Jul 24, 2025
Maintains: Overweight
Price Target: $215 → $208
Current: $170.48
Upside: +22.01%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $2.56
Upside: +36.72%
Jul 23, 2025
Maintains: Underweight
Price Target: $17 → $11
Current: $14.98
Upside: -26.57%
Jul 22, 2025
Maintains: Overweight
Price Target: $358 → $327
Current: $292.48
Upside: +11.80%
Jul 9, 2025
Maintains: Overweight
Price Target: $350 → $337
Current: $261.57
Upside: +28.84%
Jul 2, 2025
Maintains: Equal-Weight
Price Target: $65 → $45
Current: $26.17
Upside: +71.95%
Jul 2, 2025
Initiates: Equal-Weight
Price Target: $5.5
Current: $7.24
Upside: -24.03%
May 27, 2025
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $22.98
Upside: +4.44%
May 27, 2025
Maintains: Equal-Weight
Price Target: $23 → $24
Current: $20.71
Upside: +15.89%
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $29.10
Upside: +23.71%
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $63.60
Upside: -5.66%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $113.06
Upside: -26.59%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.54
Upside: +59.15%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $100.95
Upside: -5.89%